Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2018
Malachi Griffith, Ph.D.
Splicing regulatory aberrations and their role in tumor neoepitope creation
Read More
2018
Mingye Feng, Ph.D.
Programmed cell removal in cancer immunosurveillance
Read More
2018
Michael Deel, M.D.
Investigating co-activator TAZ as a regulator of PAX3-FOXO1, cancer cell stemness, and...
Read More
2018
Teresa Davoli, Ph.D.
Targeting Chromosome-Specific Aneuploidy in Colorectal Cancer
Read More
2018
Iok In (Christine) Chio, Ph.D.
Targeting redox-dependent mRNA translation in pancreatic cancer
Read More
2018
Qing Chen, M.D., Ph.D.
Imaging Tumor-Stromal Interactions during Brain Metastasis
Read More
2018
Scott Bratman, M.D., Ph.D.
Genomics-based radiosensitization for HPV-negative squamous cell carcinoma of the aerodigestive tract
Read More
2018
Paula Bos, Ph.D.
Regulatory T cell modulation of the brain pre-metastatic niche
Read More
2018
Collin Blakely, M.D., Ph.D.
Mechanisms driving tumor cell persistence in EGFR-mutant lung cancer
Read More
2018
Ami Bhatt, M.D., Ph.D.
Precisely shaping the intestinal microbiome to improve cancer therapy outcomes
Read More
2018
Olga Anczukow, Ph.D.
Uncovering Genomic Alterations in the Breast, Paving the Road to Early Cancer...
Read More
2018
Claudio Alarcon, Ph.D.
Epitranscriptomic Regulation of Cancer Metastasis
Read More
2018
Russell Ryan, M.D.
Targeting BCL6 regulatory elements in ‘enhancer hijacking’ rearrangements *The research project that...
Read More
2018
Andrei Thomas-Tikhonenko, Ph.D.
Alternative surface epitopes in pediatric acute lymphoblastic leukemia
Read More
2018
Erica Stringer-Reasor, M.D.
PARP Inhibitors: A Novel Mechanism to Overcome Resistance in Aggressive HER2+ Breast...
Read More
2018
Elliot Stieglitz, M.D.
Precision Medicine in Juvenile Myelomonocytic Leukemia
Read More